Astex Pharmaceuticals Inc. (ASTX1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
4140 DUBLIN BLVD, SUITE 200, DUBLIN, CA 94568
9255600100

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 512.333 Million Shares Outstanding60.31 Million Avg 30-day Volume 2.875 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.03
Price to Revenue4.868 Debt to Equity0.0 EBITDA-9.605 Million
Price to Book Value1.6705 Operating Margin-21.304699999999997 Enterprise Value255.284 Million
Current Ratio5.116 EPS Growth0 Quick Ratio4.776
1 Yr BETA 1.8178 52-week High/Low 0.0 / Profit Margin-1.1593
Operating Cash Flow Growth105.1812 Altman Z-Score6.7432 Free Cash Flow to Firm -3.37 Million
View SEC Filings from ASTX1 instead.

View recent insider trading info

Funds Holding ASTX1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ASTX1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CASAMENTO CHARLES J

  • Director
No longer subject to file 2013-10-11 0

GIRARDI THOMAS V

  • Director
No longer subject to file 2013-10-11 0

LACK WALTER J

  • Director
No longer subject to file 2013-10-11 0

MANUSO JAMES S J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2013-10-11 0

MOLKENTIN MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2013-10-11 0

AZAB MOHAMMAD CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2013-10-11 0

GOLDBERG ALLAN R

  • Director
No longer subject to file 2013-10-11 0

KOLA ISMAIL

  • Director
No longer subject to file 2013-10-11 0

BUCKLAND MARTIN CHIEF BUSINESS OFFICER

  • Officer
No longer subject to file 2013-10-11 0

JHOTI HARREN PRESIDENT

  • Officer
  • Director
No longer subject to file 2013-10-11 0

FELLNER PETER

  • Director
No longer subject to file 2013-10-11 0

HAINES TIMOTHY

  • Director
No longer subject to file 2013-10-11 0

YOUNG MICHAEL D

  • Director
0 2011-06-16 0

NB PUBLIC EQUITY K/S

HANSEN CHRISTIAN

SCHONHARTING FLORIAN

  • 10% Owner
6,021,017 2010-04-26 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • DIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNER
No longer subject to file 2010-04-19 0

BERK GREGORY CHIEF MEDICAL OFFICER

  • Officer
0 2009-03-12 0

BEARSS DAVID CHIEF SCIENTIFIC OFFICER

  • Officer
0 2009-03-12 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
5,753,399 2008-05-09 0

JAKUBOWSKI AUDREY F CHIEF REG & COMPLIANCE OFFICER

  • Officer
31,200 2006-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments